Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 1.090\% hERG inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) Br.CC1CCN(Cc2nnnn2-c2cccc([N+](=O)[O-])c2)CC1
(b) O=C(NCCNc1ccc2ccccc2c1)c1cccn2c(=O)c3sccc3nc12
Answer: b. O=C(NCCNc1ccc2ccccc2c1)c1cccn2c(=O)c3sccc3nc12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(NCCNc1ccc2ccccc2c1)c1cccn2c(=O)c3sccc3nc12
O=C(NCCNc1ccc2ccccc2c1)c1cccn2c(=O)c3sccc3nc12
N-[2-(naphthalen-2-ylamino)ethyl]-2-oxo-4-thia-1,8-diazatricyclo[7.4.0.03,7]trideca-3(7),5,8,10,12-pentaene-10-carboxamide